Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC and ATG in children with severe aplastic anemia
NCT02218437Phase 4Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Countries
- 1
01
Overview
Phase 4, open-label trial of human umbilical cord mesenchymal stem cells in aplastic anemia, sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Response and complete remission rate at 1 year. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT02218437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218437.